Novel Perspective for Understanding the Pathogenesis of Metabolic Diseases Focusing on a Metabolite Sensor

Historically, attempts to understand the pathogenesis of obesity have focused on hormonal perspectives, as exemplified by insulin. However, concurrent upregulation of hepatic gluconeogenesis and lipogenesis, one of the specific aspects of obesity-related pathogenesis, cannot be explained simply by i...

Full description

Saved in:
Bibliographic Details
Published inNihon Eiyō, Shokuryō Gakkai shi Vol. 78; no. 3; pp. 145 - 149
Main Author Sekiya, Motohiro
Format Journal Article
LanguageJapanese
Published Tokyo Japan Society of Nutrition and Food Science 2025
Japan Science and Technology Agency
Subjects
Online AccessGet full text
ISSN0287-3516
1883-2849
DOI10.4327/jsnfs.78.145

Cover

More Information
Summary:Historically, attempts to understand the pathogenesis of obesity have focused on hormonal perspectives, as exemplified by insulin. However, concurrent upregulation of hepatic gluconeogenesis and lipogenesis, one of the specific aspects of obesity-related pathogenesis, cannot be explained simply by insulin resistance, implying gaps in existing knowledge. C-terminal binding protein 2 (CtBP2) is a metabolite sensor that can be activated by NADH. We have demonstrated that CtBP2 is inactivated upon interaction with fatty acyl-CoAs, which are increased in tissues in obesity, thereby playing a critical role in this pathogenetic process. In the liver, CtBP2 suppresses gluconeogenesis and lipogenesis in healthy subjects but is dysregulated in obesity, leading to diabetes and steatosis. Inactivation of CtBP2 also contributes to the progressive decline of pancreatic β-cell function in obesity, suggesting possible involvement of CtBP2 in a variety of tissues. This article discusses the pathogenesis of obesity from metabolic perspectives by focusing on CtBP2.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ISSN:0287-3516
1883-2849
DOI:10.4327/jsnfs.78.145